Alnylam Pharmaceuticals, Inc. (NasdaqGS:ALNY) will seek acquisitions. The company has filed a Follow-on Equity Offering of 5,000,000 shares of its common stock, and intends to use the net proceeds from this offering for general corporate purposes, including the potential expansion into additional countries, continuing investment in its early stage pipeline, potential acquisitions.